A related study showed that FcγRIIB knockout in mice decreased CD39+Foxp3+Treg cells and M2 macrophages in gliomas[12], consistently supporting its importance in modulating adaptive and innate immunity within the GBM microenvironment. This evidence concerns the gene FCGR2B and central nervous system cancer.